Caraffa A - Search Results

1

Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.

Conti P, D'Ovidio C, Conti C, Gallenga CE, Lauritano D, Caraffa A, Kritas SK, Ronconi G. Conti P, et al. Among authors: caraffa a. Eur J Pharmacol. 2019 Feb 5;844:87-94. doi: 10.1016/j.ejphar.2018.12.004. Epub 2018 Dec 6. Eur J Pharmacol. 2019. PMID: 30529470 Review.

2

Are mast cells important in diabetes?

Kempuraj D, Caraffa A, Ronconi G, Lessiani G, Conti P. Kempuraj D, et al. Among authors: caraffa a. Pol J Pathol. 2016;67(3):199-206. doi: 10.5114/pjp.2016.63770. Pol J Pathol. 2016. PMID: 28155967 Free article. Review.

3

Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.

Conti P, Carinci F, Lessiani G, Spinas E, Kritas SK, Ronconi G, Caraffa A, Theoharides TC. Conti P, et al. Among authors: caraffa a. Immunol Res. 2017 Oct;65(5):982-986. doi: 10.1007/s12026-017-8938-7. Immunol Res. 2017. PMID: 28748328 Review.

4

Link between mast cells and bacteria: Antimicrobial defense, function and regulation by cytokines.

Conti P, Carinci F, Caraffa A, Ronconi G, Lessiani G, Theoharides TC. Conti P, et al. Among authors: caraffa a. Med Hypotheses. 2017 Sep;106:10-14. doi: 10.1016/j.mehy.2017.06.018. Epub 2017 Jun 29. Med Hypotheses. 2017. PMID: 28818263

5

Impact of mast cells in mucosal immunity of intestinal inflammation: Inhibitory effect of IL-37.

Conti P, Caraffa A, Ronconi G, Kritas SK, Mastrangelo F, Tettamanti L, Theoharides TC. Conti P, et al. Among authors: caraffa a. Eur J Pharmacol. 2018 Jan 5;818:294-299. doi: 10.1016/j.ejphar.2017.09.044. Epub 2017 Sep 29. Eur J Pharmacol. 2018. PMID: 28970014 Review.

6

Impact of Fungi on Immune Responses.

Conti P, Tettamanti L, Mastrangelo F, Ronconi G, Frydas I, Kritas SK, Caraffa A, Pandolfi F. Conti P, et al. Among authors: caraffa a. Clin Ther. 2018 Jun;40(6):885-888. doi: 10.1016/j.clinthera.2018.04.010. Epub 2018 May 8. Clin Ther. 2018. PMID: 29752039

7

Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.

Conti P, Ronconi G, Kritas SK, Caraffa A, Theoharides TC. Conti P, et al. Among authors: caraffa a. Can J Diabetes. 2018 Oct;42(5):568-573. doi: 10.1016/j.jcjd.2018.01.008. Epub 2018 Jan 31. Can J Diabetes. 2018. PMID: 29885882 Review.

8

Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Conti P, Caraffa A, Ronconi G, Conti CM, Kritas SK, Mastrangelo F, Tettamanti L, Theoharides TC. Conti P, et al. Among authors: caraffa a. Immunol Res. 2018 Jun;66(3):323-331. doi: 10.1007/s12026-018-9004-9. Immunol Res. 2018. PMID: 29907890 Review.

9

Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?

Conti P, Caraffa A, Ronconi G, Kritas SK, Mastrangelo F, Tettamanti L, Frydas I, Theoharides TC. Conti P, et al. Among authors: caraffa a. Inflamm Res. 2018 Sep;67(9):747-755. doi: 10.1007/s00011-018-1166-3. Epub 2018 Jun 30. Inflamm Res. 2018. PMID: 29961151 Review.

10

Impact of polyphenols on mast cells with special emphasis on the effect of quercetin and luteolin.

Shaik Y, Caraffa A, Ronconi G, Lessiani G, Conti P. Shaik Y, et al. Among authors: caraffa a. Cent Eur J Immunol. 2018;43(4):476-481. doi: 10.5114/ceji.2018.81347. Epub 2018 Dec 31. Cent Eur J Immunol. 2018. PMID: 30799996 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters